Medical cannabis now available to New York chronic pain patients, Oxford University announces medical cannabis research program with support of Sir Patrick Stewart, and new study reveals evidence for the potential of cannabinoids to reduce neurological damage associated with Traumatic Brain Injury. In case you missed them, here are the cannabis-related stories that caught our attention.
Medical cannabis for chronic pain takes effect in New York
The New York State Health Department announced last week that patients suffering from chronic pain will be able to qualify for medical cannabis treatment starting March 22nd.
In addition, NYHD announced the change that physician assistants will be able to certify patients for medical cannabis, as long as their supervising physician is also registered to certify patients; New York law requires physicians to register with the department to certify patients conditions for medical cannabis.
Oxford to advance cannabinoid research
The oldest university in England announced it will be teaming up with private equity company, Kingsley Capital Partners to develop new cannabinoid based medicines for chronic illnesses.
The research project is expected to utilize Oxford’s clinical expertise and research in immunology, neuroscience and cancer, to find ways of developing new treatments for those suffering with pain, cancer and inflammatory disease by studying the cellular, molecular, and systems mechanisms of cannabinoids.
Sir Patrick Stewart advocates for medical cannabis
UK actor Sir Patrick Stewart opened up about his medical cannabis use last week, revealing how he finds relief from joint pain due to arthritis. The California resident explained how he uses an infused topical spray throughout the day, and an ointment in the evenings, along with edibles.
The statement came in response to Oxford’s announcement of a medical cannabis research project. Stewart called the project “an important step forward for Britain in a field of research that has for too long been held back by prejudice, fear and ignorance.”
Medical cannabis for TBI
A new study published in the latest issue of Frontiers in Pharmacology has added to the body of research finding that cannabinoids may be a potential treatment option for traumatic brain injuries (TBI).
TBI’s develop following an outside blow to the head, when the body releases harmful mediators like proinflammatory cytokines, which lead to oxidative stress, inflammation and excitotoxicity in the brain, putting the healthy brain cells at risk. Researchers Lesley D. Schurman and Aron H. Lichtman found that cannabinoids administered immediately following a blow to the head can act as a protectant from neurological damage.
Latest posts by Victoria Mendicino (see all)
- Tips for Low-Temp Dabbing - April 5, 2017
- The Weekly Dispense: Significant Advancements for Cannabinoid Research - March 22, 2017
- Weekly Dispense: Cannabis Laws Gaining Ground Across the World - March 15, 2017